Research study Program year 2024 Source: CMS Open Payments

Amg 678 Crada

Research payments

$13,518,661

10 payments

Through program year 2024, $13,518,661 in research payments was reported against Amg 678 Crada, across 10 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$54,166	1
2023	Research	$936,046	2
2022	Research	$278,880	1
2021	Research	$2,007,496	2
2020	Research	$3,404,918	3
2019	Research	$6,837,155	1

Breakdown

Who paid Research payments · program years 2019–2024

Amgen Inc. $13,518,661 10 payments

Who received the money Research payments · program years 2019–2024

Nci Clinical Repository Organisation paid for research $9,793,227 3 payments
National Cancer Institute - National Institutes Of Health Organisation paid for research $2,999,768 4 payments
National Cancer Institute Organisation paid for research $725,666 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

Helen Chen Bethesda, MD Named on 10 payments

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.